Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Christopoulos

Showing results (261-270 of 331) with videos related to

Pageof 34
Sort By:
ACS Chemical Biology|July 25, 2019
Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic AripiprazoleCarmen Klein Herenbrink, Ravi Verma, Herman D Lim, et al.
Molecular Pharmacology|November 20, 2016
Isoform-Specific Biased Agonism of Histamine H3 Receptor AgonistsDarren M Riddy, Anna E Cook, Natalie A Diepenhorst, et al.
European Journal of Medicinal Chemistry|July 9, 2023
Design, synthesis and evaluation of novel 2-phenyl-3-(1H-pyrazol-4-yl)pyridine positive allosteric modulators for the M<sub>4</sub> mAChRManuela Jörg, Emma T van der Westhuizen, Yao Lu, et al.
Biochemical Pharmacology|March 29, 2020
Rational development of a high-affinity secretin receptor antagonistMaoqing Dong, Kaleeckal G Harikumar, Sweta R Raval, et al.
Science (New York, N.Y.)|February 19, 2021
Structure and dynamics of the CGRP receptor in apo and peptide-bound formsTracy M Josephs, Matthew J Belousoff, Yi-Lynn Liang, et al.
Biochemical Pharmacology|February 19, 2018
Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacyEmma Dal Maso, Yue Zhu, Vi Pham, et al.
Biochemical Pharmacology|January 13, 2018
The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D<sub>2</sub> receptorChristopher J Draper-Joyce, Mayako Michino, Ravi Kumar Verma, et al.
Neuropharmacology|October 26, 2018
Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H<sub>3</sub> receptor antagonistsDarren M Riddy, Anna E Cook, David M Shackleford, et al.
Science Signaling|November 15, 2022
M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative diseaseLouis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 10, 2021
Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gastrointestinal motility disordersJesse J DiCello, Simona E Carbone, Ayame Saito, et al.
Pageof 34

Showing results (261-270 of 331) with videos related to

Sort By:
Pageof 34
ACS Chemical Biology|July 25, 2019
Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic AripiprazoleCarmen Klein Herenbrink, Ravi Verma, Herman D Lim, et al.
Molecular Pharmacology|November 20, 2016
Isoform-Specific Biased Agonism of Histamine H3 Receptor AgonistsDarren M Riddy, Anna E Cook, Natalie A Diepenhorst, et al.
European Journal of Medicinal Chemistry|July 9, 2023
Design, synthesis and evaluation of novel 2-phenyl-3-(1H-pyrazol-4-yl)pyridine positive allosteric modulators for the M<sub>4</sub> mAChRManuela Jörg, Emma T van der Westhuizen, Yao Lu, et al.
Biochemical Pharmacology|March 29, 2020
Rational development of a high-affinity secretin receptor antagonistMaoqing Dong, Kaleeckal G Harikumar, Sweta R Raval, et al.
Science (New York, N.Y.)|February 19, 2021
Structure and dynamics of the CGRP receptor in apo and peptide-bound formsTracy M Josephs, Matthew J Belousoff, Yi-Lynn Liang, et al.
Biochemical Pharmacology|February 19, 2018
Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacyEmma Dal Maso, Yue Zhu, Vi Pham, et al.
Biochemical Pharmacology|January 13, 2018
The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D<sub>2</sub> receptorChristopher J Draper-Joyce, Mayako Michino, Ravi Kumar Verma, et al.
Neuropharmacology|October 26, 2018
Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H<sub>3</sub> receptor antagonistsDarren M Riddy, Anna E Cook, David M Shackleford, et al.
Science Signaling|November 15, 2022
M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative diseaseLouis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 10, 2021
Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gastrointestinal motility disordersJesse J DiCello, Simona E Carbone, Ayame Saito, et al.
Pageof 34